Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 8, 2013

Advaxis, Discovery Laboratories, Peregrine, Pfizer, Pharming, Proteo, Santarus

Preclinical
Peregrine antibody shows combo-benefit in melanoma . . . read more

Phase II
Advaxis improves 18-month survival in cervical cancer . . . read more

Elafin trial completes recruitment, treatment in CABG . . . read more

Phase III
Santarus, Pharming present Ruconest HAE results . . . read more

Rapamune misses endpoint in renal function trial . . . read more

Launches
Discovery RDS treatment hits market . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters